Céline Lepère
About
Céline Lepère is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology.
According to data from OpenAlex, Céline Lepère has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Epidemiology. Recurrent topics in Céline Lepère's work include Colorectal Cancer Treatments and Studies (17 papers), Neuroendocrine Tumor Research Advances (13 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Céline Lepère is often cited by papers focused on Colorectal Cancer Treatments and Studies (17 papers), Neuroendocrine Tumor Research Advances (13 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Céline Lepère collaborates with scholars based in France, Italy and Belgium. Céline Lepère's co-authors include Julien Taı̈eb, Thierry André, Aimery de Gramont, Christophe Louvet, Pascal Hammel, Michel Ducreux, Roger Faroux, Enrico Aitini, Gérard Lledo and Maria Giulia Zampino and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Pain.
In The Last Decade
Céline Lepère
41 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Céline Lepère France | 15 | 1.3k | 477 | 477 | 433 | 258 | 43 | 1.6k | ||
| Bhavana Konda United States | 19 | 923 0.7× | 387 0.8× | 320 0.7× | 409 0.9× | 328 1.3× | 73 | 1.7k | ||
| Luigi Celio Italy | 22 | 1.2k 1.0× | 351 0.7× | 383 0.8× | 408 0.9× | 547 2.1× | 82 | 2.2k | ||
| Fumihiko Hirai Japan | 26 | 1.1k 0.9× | 979 2.1× | 181 0.4× | 211 0.5× | 153 0.6× | 103 | 1.8k | ||
| G. Gorzegno Italy | 21 | 836 0.7× | 440 0.9× | 249 0.5× | 241 0.6× | 182 0.7× | 51 | 1.4k | ||
| Édouard Auclin France | 22 | 1.7k 1.3× | 1.1k 2.3× | 390 0.8× | 154 0.4× | 212 0.8× | 127 | 2.4k | ||
| Menghua Dai China | 21 | 1.1k 0.8× | 394 0.8× | 227 0.5× | 338 0.8× | 570 2.2× | 107 | 1.5k | ||
| Koji Murono Japan | 26 | 1.3k 1.0× | 552 1.2× | 329 0.7× | 261 0.6× | 908 3.5× | 209 | 2.2k | ||
| Ana Custodio Spain | 21 | 705 0.6× | 306 0.6× | 175 0.4× | 334 0.8× | 107 0.4× | 75 | 1.2k | ||
| Soichiro Funaki Japan | 22 | 616 0.5× | 683 1.4× | 212 0.4× | 204 0.5× | 335 1.3× | 146 | 1.7k | ||
| Yang Feng China | 23 | 643 0.5× | 353 0.7× | 204 0.4× | 179 0.4× | 212 0.8× | 75 | 1.6k |
Countries citing papers authored by Céline Lepère
Since
Specialization
Citations
This map shows the geographic impact of Céline Lepère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Lepère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Lepère more than expected).
Fields of papers citing papers by Céline Lepère
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Céline Lepère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Lepère. The network helps show where Céline Lepère may publish in the future.
Co-authorship network of co-authors of Céline Lepère
This figure shows the co-authorship network connecting the top 25 collaborators of Céline Lepère. A scholar is included among the top collaborators of Céline Lepère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Lepère. Céline Lepère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Taı̈eb, Julien, Valérie Taly, Julie Henriques, et al.. (2021). Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial. Clinical Cancer Research. 27(20). 5638–5646.
2.
Ursino, Moreno, Peter F. Thall, Bruno Landi, et al.. (2019). Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer data. Statistical Methods in Medical Research. 29(2). 541–567.
3.
Pernot, Simon, Olivier Dubreuil, Thomas Aparicio, et al.. (2018). Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study. British Journal of Cancer. 119(4). 424–428.
4.
Pernot, Simon, G. Amouyal, Marc Sapoval, et al.. (2017). 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases. Clinics and Research in Hepatology and Gastroenterology. 42(3). 255–260.
5.
Taı̈eb, Julien, Franck Bonnetain, Laurent Mineur, et al.. (2017). Three versus six months’ adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: Per-protocol, subgroups and long-lasting neuropathy results. Annals of Oncology. 28. v158–v158.
6.
Dréanic, Johann, Céline Lepère, Mostafa El Hajjam, et al.. (2016). Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?. Therapeutic Advances in Medical Oncology. 8(5). 383–387.
7.
Brieau, Bertrand, Céline Lepère, Thomas Walter, et al.. (2015). Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma. Medicine. 94(42). e1864–e1864.
8.
Taı̈eb, Julien, Christophe Borg, Thierry Lecomte, et al.. (2015). Masitinib plus FOLFIRI for second line treatment of metastatic colorectal cancer: An open label phase Ib/II trial.. Journal of Clinical Oncology. 33(15_suppl). 3526–3526.
9.
Lièvre, Astrid, Valérie Laurent, Tristan Cudennec, et al.. (2014). Management of patients over 80 years of age treated with resection for localised colon cancer: Results from a French referral centre. Digestive and Liver Disease. 46(9). 838–845.
10.
Lévi, Françis, Valérie Boige, Mohamed Hebbar, et al.. (2013). Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228).. Journal of Clinical Oncology. 31(4_suppl). 466–466.
11.
Boussaha, Tarek, Philippe Rougier, Julien Taı̈eb, & Céline Lepère. (2013). Digestive neuroendocrine tumors (DNET): The era of targeted therapies. Clinics and Research in Hepatology and Gastroenterology. 37(2). 134–141.
12.
Pernot, Simon, Emmanuel Mitry, Emmanuelle Samalin, et al.. (2013). Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort. Gastric Cancer. 17(2). 341–347.
13.
Touchefeu, Yann, Isabelle Archambeaud, Bruno Landi, et al.. (2013). Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer. Digestive and Liver Disease. 46(3). 283–286.
14.
Trouilloud, Isabelle, Olivier Dubreuil, Tarek Boussaha, et al.. (2011). Medical treatment of pancreatic cancer: New hopes after 10 years of gemcitabine. Clinics and Research in Hepatology and Gastroenterology. 35(5). 364–374.
15.
Bachet, Jean‐Baptiste, Emmanuel Mitry, Astrid Lièvre, et al.. (2009). Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: Feasibility and potential benefits in a retrospective series of 117 patients. Gastroentérologie Clinique et Biologique. 33(10-11). 1036–1044.
16.
Mitry, Emmanuel, Nicolas Mansencal, Céline Lepère, et al.. (2007). Risk of venous thrombosis in patients with pancreatic adenocarcinoma. Gastroentérologie Clinique et Biologique. 31(12). 1139–1142.
17.
Bachet, Jean‐Baptiste, Emmanuel Mitry, Céline Lepère, et al.. (2007). Chemotherapy as initial treatment of locally advanced unresectable pancreatic cancer: a valid option?. Gastroentérologie Clinique et Biologique. 31(2). 151–156.
18.
Mansencal, Nicolas, Emmanuel Mitry, Alban Redheuil, et al.. (2006). Assessment of patent foramen ovale in carcinoid heart disease. American Heart Journal. 151(5). 1129.e1–1129.e6.
19.
Louvet, Christophe, Roberto Labianca, Pascal Hammel, et al.. (2005). Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial. Journal of Clinical Oncology. 23(15). 3509–3516.
20.
Lepère, Céline, Emmanuel Cuillerier, A. Van Gossum, et al.. (2005). Predictive factors of positive findings in patients explored by push enteroscopy for unexplained GI bleeding. Gastrointestinal Endoscopy. 61(6). 709–714.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bhavana Konda Breakdown of academic impact, for papers by Luigi Celio Breakdown of academic impact, for papers by Fumihiko Hirai Breakdown of academic impact, for papers by G. Gorzegno Breakdown of academic impact, for papers by Édouard Auclin Breakdown of academic impact, for papers by Menghua Dai Breakdown of academic impact, for papers by Koji Murono Breakdown of academic impact, for papers by Ana Custodio Breakdown of academic impact, for papers by Soichiro Funaki Breakdown of academic impact, for papers by Yang Feng